Cyteir Therapeutics Price on December 2, 2024
CYTDelisted Stock | USD 2.76 0.01 0.36% |
If you're considering investing in Cyteir Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cyteir Therapeutics stands at 2.76, as last reported on the 10th of December, with the highest price reaching 2.81 and the lowest price hitting 2.75 during the day. We have found thirty technical indicators for Cyteir Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Cyteir Therapeutics' Mean Deviation of 2.76, downside deviation of 3.55, and Risk Adjusted Performance of 0.0842 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cyteir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cyteir |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CYT |
Based on monthly moving average Cyteir Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyteir Therapeutics by adding Cyteir Therapeutics to a well-diversified portfolio.
Related Headline
Prelude Therapeutics Headline on 2nd of December 2024
Morgan Stanley Downgrades Prelude Therapeutics - MSN by news.google.com
Morgan Stanley Downgrades Prelude Therapeutics MSN
Cyteir Therapeutics Valuation on December 2, 2024
It is possible to determine the worth of Cyteir Therapeutics on a given historical date. On December 2, 2024 Cyteir was worth 2.75 at the beginning of the trading date compared to the closed value of 2.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cyteir Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cyteir Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cyteir Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cyteir Therapeutics' related companies.
Open | High | Low | Close | Volume | |
12/10/2024 | 2.75 | 2.81 | 2.75 | 2.76 | 0.00 |
Backtest Cyteir Therapeutics | | | Cyteir Therapeutics History | | | Cyteir Therapeutics Valuation |
Cyteir Therapeutics Trading Date Momentum on December 2, 2024
Cyteir Therapeutics Fundamentals Correlations and Trends
By evaluating Cyteir Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cyteir Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cyteir financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cyteir Therapeutics Stock history
Cyteir Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cyteir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cyteir Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cyteir Therapeutics stock prices may prove useful in developing a viable investing in Cyteir Therapeutics
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. The company was incorporated in 2012 and is based in Lexington, Massachusetts. Cyteir Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
Cyteir Therapeutics Stock Technical Analysis
Cyteir Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Cyteir Therapeutics Period Price Range
Low | December 10, 2024
| High |
0.00 | 0.00 |
Cyteir Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cyteir Therapeutics December 10, 2024 Market Strength
Market strength indicators help investors to evaluate how Cyteir Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cyteir Therapeutics shares will generate the highest return on investment. By undertsting and applying Cyteir Therapeutics stock market strength indicators, traders can identify Cyteir Therapeutics entry and exit signals to maximize returns
Cyteir Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cyteir Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cyteir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cyteir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0842 | |||
Jensen Alpha | 0.5644 | |||
Total Risk Alpha | (0.31) | |||
Sortino Ratio | 0.1273 | |||
Treynor Ratio | 41.01 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Cyteir Stock
If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |